Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Bortezomib

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCHEM1701

    09/25/2017

    Phase 2, Randomized, Open-Label Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Chemotherapy and Autologous Stem Cell Transplantation

    Treatment

    VICCHEMP1558

    10/09/2015

    A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB052793 in Subjects With Advanced Malignancies


    Print this page for your doctor